TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Kessler Topaz Meltzer & Check, Llp
NASDAQ: QURE Investigation Reminder:  Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

uniQure N.V. experienced a significant stock price drop after the FDA indicated insufficient evidence to support its Biologics License Application for AMT-130, a gene therapy for Huntington's disease.

Insights
TGT   positive

Successfully adapted digital strategy during pandemic, maintains consistent dividend payments since 1967, offers unique in-store shopping experience, and continues investing in growth and innovation


QURE   negative

Stock price fell over 50% after FDA notification that clinical data was inadequate for Biologics License Application submission, suggesting significant regulatory and developmental challenges for the company's gene therapy treatment